• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

    1.140 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,519,056
    Open 1.150
    Bid (Size) 1.120 (1,900)
    Ask (Size) 1.190 (300)
    Prev. Close 1.140
    Today's Range 1.139 - 1.195
    52wk Range 1.030 - 2.979
    Shares Outstanding 210,356,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire

    Performance

    YTD
    -32.5%
    -32.5%
    1 Month
    +0.9%
    +0.9%
    3 Month
    -32.9%
    -32.9%
    6 Month
    -54.4%
    -54.4%
    1 Year
    -40.6%
    -40.6%

    More News

    Read More
    News headline image
    INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th
    From Bragar Eagel & Squire
    Via GlobeNewswire
    On Monday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    What's Behind The Drop In Inovio Pharmaceuticals Stock Today? ↗
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Discover the top movers in Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Robbins LLP Reminds Inovio Pharmaceuticals, Inc. Stockholders of the Pending Class Action Against INO and Urges Harmed Stockholders to Seek More Information
    From Robbins LLP
    Via Business Wire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?
    Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market
    What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?
    The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.140
    When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 05/05/26 04:00 PM ET
    What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 239.81M
    How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?
    Inovio Pharmaceuticals, Inc. - Common Stock has 240M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.